Pfizer Starts Diabetes Research and 3 Stocks At 52-Week Highs
Martin Marietta Materials (NYSE:MLM): Closing price $101.96
Southeastern has reduced its position in Martin Marietta from 7 to 4.9 percent. Shares closed down 0.04 percent on Wednesday at $101.96, and have been traded in a 52-week range of $63.64 to $106.22.
Norfolk Southern Corp (NYSE:NSC): Closing price $76.28
The Wall Street Journal Freight says that railroads in North America are in the middle of a building boom, making them major players in the nation’s commercial transport system. Shares closed up 0.7 percent on the day at $76.28, having been traded in a 52-week range of $56.05 to $76.26.
Paychex (NASDAQ:PAYX): Closing price $34.76
Notable companies reporting after the Wednesday market close, each showing their earnings consensus, include Paychex consensus 39 cents; PVH Corp. (NYSE:PVH), $1.50; Red Hat (NYSE:RHT), 30 cents; Five Below (FIVE), 38 cents; HB Fuller Co. (NYSE:FUL), 50 cents; Steelcase (NYSE:SCS), 19 cents; Texas Industries (NYSE:TXI), (41 cents); Verint Systems (NASDAQ:VRNT), 75 cents; SYNNEX Corp. (NYSE:SNX), 88 cents; Progress Software Corp. (NASDAQ:PRGS), 24 cents; and The ExOne Company (XONE), 8 cents. shares closed down 0.23 percent on the day at $34.76, and have been traded in a 52-week range of $29.12 to $34.91.
Pfizer (NYSE:PFE): Closing price $28.64
KineMed has reported the renewal of a non-exclusive research partnership with Pfizer to promote novel approaches towards metabolic disease, in particular, Type II Diabetes. The collaboration will use KineMed’s unique dynamic proteomics tech platform so as to map the impact of potential drug candidates on specific metabolic pathways. Shares closed up 0.14 percent on Wednesday at $28.64, having been traded in a 52-week range of $21.40 to $28.40.